You are here

Sanofi

Sanofi inks €250M bispecific small molecule diabetes deal

Sanofi inks €250M bispecific small molecule diabetes deal

Fierce Biotech

small molecule drugs

Flag link:

Just what Sanofi and Regeneron wanted: A Dupixent rollout so zippy, it's fueling bigger sales forecasts

Just what Sanofi and Regeneron wanted: A Dupixent rollout so zippy, it's fueling bigger sales forecasts

Fierce Pharma

Flag link:

5 Big Drugmakers With Important Catalysts in May

5 Big Drugmakers With Important Catalysts in May

Motley Fool

nonacog beta pegol

Flag link:

Sanofi enjoys solid Q1, despite continuing erosion of Lantus sales in U.S.

Sanofi enjoys solid Q1, despite continuing erosion of Lantus sales in U.S.

Fierce Pharma

Flag link:

Sarepta CEO Exits Along With a Sanofi Director, So Let's Speculate About a Possible Deal

Sarepta CEO Exits Along With a Sanofi Director, So Let's Speculate About a Possible Deal

TheStreet.com

Sarepta Therapeutics

Flag link:

Q1 Earnings Preview: AbbVie, AstraZeneca, BMS, Celgene, Roche, Sanofi

Q1 Earnings Preview: AbbVie, AstraZeneca, BMS, Celgene, Roche, Sanofi

BioPharma Dive

Bristol-Myers Squibb

Flag link:

Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent® (alirocumab) Injection

Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent® (alirocumab) Injection

Yahoo

Flag link:

Sanofi Sues Mylan Over EpiPen Practices

Sanofi Sues Mylan Over EpiPen Practices

TheStreet.com

Flag link:

EMA panel recommends nod for Sanofi, Regeneron's arthritis drug

EMA panel recommends nod for Sanofi, Regeneron's arthritis drug

Yahoo/Reuters

rheumatoid arthritis

Flag link:

Sanofi Epilepsy Drug Responsible for Birth Defects in 4,100 Children, French Regulator Says

Sanofi Epilepsy Drug Responsible for Birth Defects in 4,100 Children, French Regulator Says

TheStreet.com

Flag link:

Meet the lawyer trying to pry drug pricing secrets out of Big Pharma

Meet the lawyer trying to pry drug pricing secrets out of Big Pharma

Stat

Flag link:

Sanofi says could buy device assets to boost diabetes

Sanofi says could buy device assets to boost diabetes

Yahoo/Reuters

blood glucose monitoring

Flag link:

When do pharmas disclose launch prices up front? When they’re pricing at a discount

When do pharmas disclose launch prices up front? When they’re pricing at a discount

Fierce Pharma

Flag link:

Sanofi Buying Flexion: A Smart Move?

Sanofi Buying Flexion: A Smart Move?

Motley Fool

osteoarthritis of the knee

Flag link:

Sanofi May Now Have Moved Past Its Most Challenging Period, Analyst Initiates At Buy

Sanofi May Now Have Moved Past Its Most Challenging Period, Analyst Initiates At Buy

Yahoo/Benzinga

Flag link:

GSK, Sanofi, Bayer and Lilly join parade of advertisers marching off Fox News host O’Reilly’s TV show

GSK, Sanofi, Bayer and Lilly join parade of advertisers marching off Fox News host O’Reilly’s TV show

Fierce Pharma

Flag link:

Sanofi to pay $19 million for VA drug overcharges

Sanofi to pay $19 million for VA drug overcharges

Modern Healthcare

Flag link:

Lilly, Pfizer, et al. back Sanofi and Regeneron in PCSK9 patent appeal. AbbVie doesn't

Lilly, Pfizer, et al. back Sanofi and Regeneron in PCSK9 patent appeal. AbbVie doesn't

Fierce Pharma

PCSK9 inhibitors

Flag link:

Sanofi boasts observational hypoglycemia rates for Toujeo insulin injection

Sanofi boasts observational hypoglycemia rates for Toujeo insulin injection

Mass Device

Flag link:

Regeneron's Game-Changing New Eczema Drug Could Be a Blockbuster

Regeneron's Game-Changing New Eczema Drug Could Be a Blockbuster

Motley Fool

Flag link:

Pages